Genprex Inc
(NAS:GNPX)
$
1.91
-0.06 (-3.05%)
Market Cap: 4.01 Mil
Enterprise Value: -4.21 Mil
PE Ratio: 0
PB Ratio: 0.42
GF Score: 31/100 Genprex Inc (GNPX) Transcripts
- Genprex Inc Global One Media Interview TranscriptJun 22, 2023
- Genprex Inc at Sidoti & Company May Micro-Cap Virtual Conference TranscriptMay 11, 2023
- Genprex Inc KOL Event: Novel Gene Therapy to Treat Type 1 Diabetes TranscriptApr 12, 2023
- Genprex Inc at LD Micro Main Event TranscriptOct 26, 2022
- Genprex Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Genprex Inc at LD Micro Invitational Conference (Virtual) TranscriptJun 08, 2022
- Genprex Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 20, 2022
- Genprex Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 29, 2021
- Genprex Inc C-Suite Interview with Noble Capital Markets TranscriptApr 22, 2021
- Cell and Gene Meeting on Mesa - Genprex TranscriptJan 08, 2021
- Genprex launches new branding for its lead drug REQORSA in preparation for upcoming studies TranscriptNov 06, 2020
- Genprex (GNPX) Virtual Road Show with CEO Rodney Varner TranscriptSep 15, 2020
- Genprex (GNPX) Channelchek C-Suite Series, CEO Rodney Varner interview with Noble's Dr. Ahu Demir TranscriptAug 04, 2020
- 1